Table 1

Characteristics of patients with and without MAFLD

Subgroups	Mean±SD	All N=204 394	Non-MAFLD n=132 638	MAFLD n=71 756	Prevalence (%)	P value
Age (years)						<0.001
20–29		22 822	18 728	4094	17.94
30–39		80 227	54 671	25 556	31.85
40–49		44 464	27 913	16 551	37.22
50–59		30 861	17 173	13 688	44.35
≥60		26 020	14 153	11 867
Sex						<0.001
Male	38.8±13.7	111 782	60 222	51 560	46.13
Female	40.5±13.3	92 612	72 416	20 196	21.81
BMI (kg/m²)						<0.001
<23		79 271	74 124	5147	6.49
≥23		125 123	58 514	66 609	53.23
City						<0.001
Shenyang	39.3±12.7	78 329	50 265	28 064	36.83
Dandong	47.8±14.1	42 039	25 048	16 991	40.42
Dalian	36.3±12.7	84 026	57 325	26 701	31.78
Overall	39.6±13.6	204 394	132 638	71 756	35.11

BMI, body mass index; MAFLD, metabolic-associated fatty liver disease.